Works matching IS 02724391 AND DT 2021 AND VI 82 AND IP 8
Results: 19
Disruption of the biological activity of protease‐activated receptors2/4 in adults rather than children in SARS CoV‐2 virus‐mediated mortality in COVID‐19 infection.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1075, doi. 10.1002/ddr.21874
- By:
- Publication type:
- Article
Recent advances in trophoblast cell‐surface antigen 2 targeted therapy for solid tumors.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1096, doi. 10.1002/ddr.21870
- By:
- Publication type:
- Article
The recent development of thymol derivative as a promising pharmacological scaffold.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1079, doi. 10.1002/ddr.21848
- By:
- Publication type:
- Article
Tanshinol alleviates ulcerative colitis by promoting the expression of VLDLR.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1258, doi. 10.1002/ddr.21840
- By:
- Publication type:
- Article
Dasatinib protects against acute respiratory distress syndrome via Nrf2‐regulated M2 macrophages polarization.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1247, doi. 10.1002/ddr.21839
- By:
- Publication type:
- Article
A quinazoline‐based bromodomain inhibitor, CN210, ameliorates indomethacin‐induced ileitis in mice by inhibiting inflammatory cytokine expression.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1235, doi. 10.1002/ddr.21838
- By:
- Publication type:
- Article
SOX4‐induced upregulation of ARHGAP9 promotes the progression of acute myeloid leukemia.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1227, doi. 10.1002/ddr.21837
- By:
- Publication type:
- Article
Proteolytic degradation patterns of the receptor for advanced glycation end products peptide fragments correlate with their neuroprotective activity in Alzheimer's disease models.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1217, doi. 10.1002/ddr.21836
- By:
- Publication type:
- Article
CircMYLK promotes the growth, migration, invasion, and survival of bladder cancer cells by upregulating CCND3 level via competitively binding to miR‐34a.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1206, doi. 10.1002/ddr.21835
- By:
- Publication type:
- Article
CircMYBL2 regulates the resistance of cervical cancer cells to paclitaxel via miR‐665‐dependent regulation of EGFR.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1193, doi. 10.1002/ddr.21834
- By:
- Publication type:
- Article
Identification of kinases and kinase inhibitors for the differential targeting of Wnt/β‐catenin signaling in gastric cancer subtypes.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1182, doi. 10.1002/ddr.21833
- By:
- Publication type:
- Article
New isolate from Salvinia molesta with antioxidant and urease inhibitory activity.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1169, doi. 10.1002/ddr.21831
- By:
- Publication type:
- Article
Investigating function of long noncoding RNA of HOTAIRM1 in progression of SKOV3 ovarian cancer cells.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1162, doi. 10.1002/ddr.21821
- By:
- Publication type:
- Article
Repurposing of FDA‐approved drugs as inhibitors of sterol C‐24 methyltransferase of Leishmania donovani to fight against leishmaniasis.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1154, doi. 10.1002/ddr.21820
- By:
- Publication type:
- Article
Changes in the proportions of an active pharmaceutical through cocrystals.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1144, doi. 10.1002/ddr.21818
- By:
- Publication type:
- Article
CircFAT1 facilitates cervical cancer malignant progression by regulating ERK1/2 and p38 MAPK pathway through miR‐409‐3p/CDK8 axis.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1131, doi. 10.1002/ddr.21816
- By:
- Publication type:
- Article
Potential antiviral activity of isorhamnetin against SARS‐CoV‐2 spike pseudotyped virus in vitro.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1124, doi. 10.1002/ddr.21815
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1073, doi. 10.1002/ddr.21697
- Publication type:
- Article
CQMUH‐011 mitigates autoimmune hepatitis via inhibiting the function of T lymphocytes.
- Published in:
- Drug Development Research, 2021, v. 82, n. 8, p. 1111, doi. 10.1002/ddr.21813
- By:
- Publication type:
- Article